Specialtypharmaceutical company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) todayannounced that it has lodged the registration documents for marketingapproval of its asthma management product, Aridol, with the Swissregulatory agency for therapeutic products, Swissmedic. Aridol will bedistributed by Trimedal AG, a specialist respiratory and allergypharmaceutical company based in Zurich. [click link for full article]
(more...)